PE20120328A1 - Sales de adicion de trometamina con derivados de acido azabifenilaminobenzoico como inhibidores de dhodh - Google Patents

Sales de adicion de trometamina con derivados de acido azabifenilaminobenzoico como inhibidores de dhodh

Info

Publication number
PE20120328A1
PE20120328A1 PE2011001597A PE2011001597A PE20120328A1 PE 20120328 A1 PE20120328 A1 PE 20120328A1 PE 2011001597 A PE2011001597 A PE 2011001597A PE 2011001597 A PE2011001597 A PE 2011001597A PE 20120328 A1 PE20120328 A1 PE 20120328A1
Authority
PE
Peru
Prior art keywords
trometamine
acid
salt
benzoic
amino
Prior art date
Application number
PE2011001597A
Other languages
English (en)
Inventor
Gonzalez Nuria Garcia
Carrera Francesc Carrera
Jane Montserrat Julia
Laurent Debethune
Masia Xavier Serra
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40671396&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20120328(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of PE20120328A1 publication Critical patent/PE20120328A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

REFERIDA A UNA SAL DE ADICION CRISTALINA DE TROMETAMINA CON UN DERIVADO DE ACIDO DE AZABIFENILAMINOBENZOICO DE FORMULA (I), DONDE R1 ES ALQUILO C1-C4, CICLOALQUILO C3-C4 Y CF3; G1 ES N, CH, C(CH3) O C(CF3); G2 ES UN GRUPO FENILO OPCIONALMENTE SUSTITUIDO CON CLORO, FLUORO, METOXI, ETOXI, ISOPROPOXI, TRIFLUOROMETOXI, CF3, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: SAL DE TROMETAMINA DE ACIDO 5-CICLOPROPIL-2-{[2-(2,6-DIFLUOROFENIL)PIRIMIDIN-5-IL]AMINO}BENZOICO, SAL DE TROMETAMINA DE ACIDO 5-CICLOPROPIL-2-{[2-(2-(TRIFLUOROMETIL)FENIL)PIRIMIDIN-5-IL]AMINO}BENZOICO, SAL DE TROMETAMINA DE ACIDO 5-METIL-2-{[6-(2,3-DIFLUOROFENIL)PIRIDIN-3-IL]AMINO}BENZOICO, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHAS SALES INHIBEN LA DIHIDROOROATO DESHIDROGENASA (DHODH) Y SON UTILES EN EL TRATAMIENTO DE ARTRITIS REUMATOIDE, ESCLEROSIS MULTIPLE, PSORIASIS, ENTRE OTRAS
PE2011001597A 2009-03-13 2010-03-11 Sales de adicion de trometamina con derivados de acido azabifenilaminobenzoico como inhibidores de dhodh PE20120328A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09382032A EP2230232A1 (en) 2009-03-13 2009-03-13 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors

Publications (1)

Publication Number Publication Date
PE20120328A1 true PE20120328A1 (es) 2012-03-29

Family

ID=40671396

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011001597A PE20120328A1 (es) 2009-03-13 2010-03-11 Sales de adicion de trometamina con derivados de acido azabifenilaminobenzoico como inhibidores de dhodh

Country Status (21)

Country Link
US (1) US20120003183A1 (es)
EP (2) EP2230232A1 (es)
JP (1) JP2012520251A (es)
KR (1) KR20110126695A (es)
CN (1) CN102341372A (es)
AR (1) AR075737A1 (es)
AU (1) AU2010223527A1 (es)
CA (1) CA2754785A1 (es)
CL (1) CL2011002213A1 (es)
CO (1) CO6501157A2 (es)
EA (1) EA201101298A1 (es)
EC (1) ECSP11011384A (es)
IL (1) IL214517A0 (es)
MX (1) MX2011009147A (es)
NZ (1) NZ594491A (es)
PE (1) PE20120328A1 (es)
SG (2) SG10201400568PA (es)
TW (1) TW201033177A (es)
UY (1) UY32465A (es)
WO (1) WO2010102825A1 (es)
ZA (1) ZA201105743B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319596B1 (es) 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
UY31272A1 (es) 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
EP2135610A1 (en) * 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Combination comprising DHODH inhibitors and methotrexate
EP2239256A1 (en) 2009-03-13 2010-10-13 Almirall, S.A. Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
EP2314577A1 (en) 2009-10-16 2011-04-27 Almirall, S.A. Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid
CN110903219A (zh) * 2018-09-18 2020-03-24 广东东阳光药业有限公司 酰胺衍生物的盐及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804343D0 (en) 1998-02-27 1998-04-22 Univ Cardiff Chemical compounds
PT1381356E (pt) 2001-04-05 2008-07-24 Aventis Pharma Inc Utilização de (4' -trifluorometilfenil) - amida do ácido (z) -2- ciano-3-hidroxi-but-2-enóico para tratamento da esclerose múltipla
PE20030120A1 (es) * 2001-06-19 2003-02-12 Merck & Co Inc Sal amina de un antagonista de receptor de integrin
MXPA04000224A (es) 2001-07-10 2005-07-25 4Sc Ag Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos.
WO2004056746A1 (en) 2002-12-23 2004-07-08 4Sc Ag Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
AU2003300530A1 (en) 2002-12-23 2004-07-14 4Sc Ag Dhodh-inhibitors and method for their identification
WO2006001961A2 (en) 2004-05-21 2006-01-05 The Uab Research Foundation Compositions and methods relating to pyrimidine synthesis inhibitors
WO2006022442A1 (ja) 2004-08-24 2006-03-02 Santen Pharmaceutical Co., Ltd. ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
AU2005295511A1 (en) 2004-10-19 2006-04-27 Aventis Pharmaceuticals Inc. Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease
UY31272A1 (es) 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico

Also Published As

Publication number Publication date
JP2012520251A (ja) 2012-09-06
UY32465A (es) 2010-05-31
SG173824A1 (en) 2011-09-29
AU2010223527A1 (en) 2011-08-25
CL2011002213A1 (es) 2012-03-09
EA201101298A1 (ru) 2012-04-30
US20120003183A1 (en) 2012-01-05
ZA201105743B (en) 2012-04-25
CN102341372A (zh) 2012-02-01
ECSP11011384A (es) 2011-11-30
IL214517A0 (en) 2011-09-27
WO2010102825A1 (en) 2010-09-16
SG10201400568PA (en) 2014-07-30
CA2754785A1 (en) 2010-09-16
MX2011009147A (es) 2011-09-15
EP2406222A1 (en) 2012-01-18
TW201033177A (en) 2010-09-16
EP2230232A1 (en) 2010-09-22
CO6501157A2 (es) 2012-08-15
NZ594491A (en) 2013-11-29
AR075737A1 (es) 2011-04-20
KR20110126695A (ko) 2011-11-23

Similar Documents

Publication Publication Date Title
PE20120328A1 (es) Sales de adicion de trometamina con derivados de acido azabifenilaminobenzoico como inhibidores de dhodh
PE20090903A1 (es) Derivados de acido azabifenilaminobenzoico como inhibidores de la dihidroorotato deshidrogenasa
PE20090361A1 (es) Acidos benzoilamino-indan-2-carboxilicos sustituidos como inhibidores de cxcr5
PE20141726A1 (es) Heterociclilaminas como inhibidores de pi 3k
PE20120355A1 (es) DERIVADOS DE PIRAZOL COMO INHIBIDORES DE LA ENZIMA 11ßHSD1
PE20091002A1 (es) Analogos dipeptidos como inhibidores del factor de coagulacion
PE20141404A1 (es) Derivados de tieno[3,2-d]pirimidina que tienen actividad inhibidora por las quinasas de las proteinas
PE20120552A1 (es) Combinaciones que comprenden metotrexato e inhibidores de dhodh
EA201201378A1 (ru) Определенные аминопиримидины, композиции на их основе и способы их использования
PE20140188A1 (es) Co-cristales y sales de inhibidores de ccr3
PE20121180A1 (es) (heteroarilmetil) tiohidantoinas sustituidas como drogas anticancer
PE20110136A1 (es) Compuestos organicos
PE20141361A1 (es) Compuesto heterociclico dihidroxi aromatico
HK1165954A1 (en) Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
PE20081888A1 (es) ANALOGOS DE PIRAZOLOPIRIMIDINA Y SU USO COMO INHIBIDORES DE CINASA mTOR Y CINASA PI3
PE20120505A1 (es) Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona como moduladores de pde9a
PE20091828A1 (es) Derivados de acido ciclopentanocarboxilico condensados sustituidos con acilamino como inhibidores de edg-2
PE20121335A1 (es) Compuestos derivados de amida como inhibidores de raf cinasas
UA111869C2 (uk) Сполуки 2-(заміщений феніл)-циклопентан-1,3-діону та їх похідні
PE20080552A1 (es) Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasa
UY33226A (es) Compuestos de pirrolopirimidina deuterada como inhibidores de la cdk4/6
PE20090210A1 (es) Compuestos derivados de pirazolo pirimidina como inhibidores de jak quinasa
PE20141700A1 (es) Compuestos de 2-(2,4,5-anilino sustituido) pirimidina
NI201000229A (es) Composiciones fungicidas.
PE20081704A1 (es) Derivados de azacicloalcanos como inhibidores de estearoil-coenzima a delta-9 desaturasa

Legal Events

Date Code Title Description
FC Refusal